Beyond Meat and the American Cancer Society announced a multi-year agreement to advance research on plant-based meat and cancer prevention, as well as to help ACS continue to build the foundation of plant-based meat and diet data collection. The commitment aims to advance the understanding of how plant-based meats contribute to healthy diet patterns and their potential role in cancer prevention and is a crucial step towards long-term research in the plant-based protein field. The agreement will help enable a continuation of ACS’ ongoing data collection in its Cancer Prevention Study-3 and help build a downstream cancer research portfolio that is critical to understanding whether plant-based proteins, including plant-based meat, can play a role in cancer prevention. ACS’ Cancer Prevention Studies help researchers identify cancer risk factors among its pool of more than 300,000 participants.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on BYND:
- Beyond Meat price target lowered to $10 from $22 at Bernstein
- Beyond Meat price target lowered to $11 from $27 at Mizuho
- Beyond Meat (NASDAQ:BYND) Misses Q3 Earnings as Revenue Declines Sharply
- Beyond Meat sees Q4 operating expenses mid-$60M range
- Beyond Meat cuts FY22 revenue view to $400M-$425M from $470M-$520M